
Surgalign Holdings SRGA
Quarterly report 2023-Q1
added 05-11-2023
Country |
|
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
6.56 M |
Market Cap[1] |
$ 1.68 M |
EBITDA (LTM) |
$ -27.5 M |
P/E (LTM) |
- |
P/S (LTM) |
0.02 |
EPS (LTM) |
-3.52 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Abbott Laboratories
ABT
|
$ 104.93 | 0.34 % | $ 183 B | NYSE,SPB | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Align Technology
ALGN
|
$ 167.25 | -5.68 % | $ 12.5 B | Nasdaq Global Select Market,SPB | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Accuray Incorporated
ARAY
|
$ 0.4 | 6.74 % | $ 41.1 M | Nasdaq Global Select Market | ||
|
Alphatec Holdings
ATEC
|
$ 11.08 | -3.82 % | $ 1.66 B | Nasdaq Global Select Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Bruker Corporation
BRKR
|
$ 34.41 | -2.65 % | $ 5.13 K | Nasdaq Global Select Market,SPB | ||
|
Boston Scientific Corporation
BSX
|
$ 69.2 | -1.38 % | $ 102 B | NYSE,SPB | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
ClearPoint Neuro
CLPT
|
$ 9.17 | -2.34 % | $ 260 M | Nasdaq Capital Market | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
CONMED Corporation
CNMD
|
$ 35.66 | -2.67 % | $ 1.11 B | NYSE,SPB | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
NanoVibronix
NAOV
|
- | - | $ 1.08 M | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Electromed
ELMD
|
$ 24.33 | -0.51 % | $ 206 M | NYSE American | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.59 | -1.62 % | $ 32.1 M | Nasdaq Capital Market | ||
|
Aethlon Medical
AEMD
|
$ 2.21 | -2.64 % | $ 3.45 M | Nasdaq Capital Market | ||
|
Establishment Labs Holdings
ESTA
|
$ 56.38 | -5.9 % | $ 1.67 B | Nasdaq Capital Market | ||
|
Edwards Lifesciences Corporation
EW
|
$ 79.29 | -3.42 % | $ 46.4 B | NYSE,SPB | ||
|
PAVmed
PAVM
|
$ 8.75 | -2.13 % | $ 63.3 M | Nasdaq Capital Market | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
FONAR Corporation
FONR
|
$ 18.54 | -0.03 % | $ 122 M | Nasdaq Capital Market | ||
|
InspireMD
NSPR
|
$ 1.65 | -4.75 % | $ 106 M | NYSE American | ||
|
Helius Medical Technologies
HSDT
|
$ 1.92 | -4.48 % | $ 1.17 M | Nasdaq Capital Market | ||
|
Integra LifeSciences Holdings Corporation
IART
|
$ 9.36 | -0.21 % | $ 721 M | Nasdaq Global Select Market,SPB | ||
|
Inogen
INGN
|
$ 6.3 | -3.08 % | $ 168 M | Nasdaq Global Select Market,SPB | ||
|
AdaptHealth Corp.
AHCO
|
$ 11.2 | -1.84 % | $ 1.51 B | Nasdaq Capital Market | ||
|
IRIDEX Corporation
IRIX
|
$ 0.97 | -28.0 % | $ 15.6 M | Nasdaq Global Select Market | ||
|
IRadimed Corporation
IRMD
|
$ 97.63 | -1.12 % | $ 1.24 B | Nasdaq Global Select Market | ||
|
Penumbra
PEN
|
$ 335.13 | -0.38 % | $ 13 B | NYSE,SPB | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 15.74 | -3.73 % | $ 369 M | Nasdaq Global Select Market,SPB | ||
|
LivaNova PLC
LIVN
|
$ 61.48 | -3.41 % | $ 3.35 B | Nasdaq Global Select Market | ||
|
LENSAR
LNSR
|
$ 5.59 | 1.27 % | $ 64.4 M | Nasdaq Capital Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.